Hi there!
We track 70,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

VisionHealth supports patients with chronic lung diseases who are dependent on their inhaler. Whether asthma therapy or COPD therapy - our digital solution Kata® enhances inhalation therapy and…

VisionHealth supports patients with chronic lung diseases who are dependent on their inhaler. Whether asthma therapy or COPD therapy - our digital solution Kata® enhances inhalation therapy and…
Product: Kata® — a certified medical app to optimize inhalation technique and adherence for asthma and COPD
Founded / HQ: 2017; Munich, Germany
Employees: 20
Recent funding: €3 million pre‑series A (Feb 2023); prior €1.5 million (Feb 2021)
Regulatory: EU MDR (MDR 2017/745) and EN ISO 13485 certified
Chronic respiratory diseases (asthma, COPD); inhaler technique and medication adherence.
2017
Digital therapeutics; Respiratory health; Medtech
€1.5 million
Raised to fund a DiGA pivotal study and market preparation
€3 million
Raised to finance extended COPD and asthma study
“DB Specialty Invest and listed business angels/private investors participated”
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
82,000+
Open Roles
3,800+
New This Week